Recent Trends in the Diagnostic and Surgical Management of Benign Prostatic Hyperplasia in the U.S. from 2004 to 2017 : Annual Changes in the Selection of Treatment Options and Medical Costs
Del Giudice, Francesco (Stanford University School of Medicine. Department of Urology.)
Oh, Jin Kyu (Gachon University Gil Medical Center. Department of Urology. Gachon University College of Medicine)
Basran, Satvir (Stanford University School of Medicine. Department of Urology.)
Nicaise, Edouard (Massachusetts General Hospital (Boston))
Song, Phil Hyun (College of Medicine. Yeungnam University. Department of Urology.)
Kim, Wansuk (College of Medicine. Inje University. Busan Paik Hospital. Department of Urology.)
Kim, Sang Youn (Seoul National University Hospital. Department of Radiology)
Min, Gyeong Eun (Kyung Hee University School of Medicine. Kyung Hee University Hospital at Gangdong. Department of Urology.)
Yoo, Koo Han (Kyung Hee University School of Medicine. Kyung Hee University Hospital at Gangdong. Department of Urology.)
Cho, Hyuk Jin (College of Medicine. Catholic University. Department of Urology.)
Lee, Sinyeong (Seoul Medical Center. Department of Urology.)
Sciarra, Alessandro (Sapienza University of Rome. Policlinico Umberto I Hospital. Department of Maternal Infant and Urologic Sciences)
Salciccia, Stefano (Sapienza University of Rome. Policlinico Umberto I Hospital. Department of Maternal Infant and Urologic Sciences)
De Berardinis, Ettore (Sapienza University of Rome. Policlinico Umberto I Hospital. Department of Maternal Infant and Urologic Sciences)
Asero, Vincenzo (Sapienza University of Rome. Policlinico Umberto I Hospital. Department of Maternal Infant and Urologic Sciences)
Scornajenghi, Carlo Maria (Policlinico Umberto I Hospital. Department of Maternal Infant and Urologic Sciences. Sapienza University of Rome)
Pradere, Benjamin (Medical University of Vienna)
Krajewski, Wojciech (Department of Minimally Invasive and Robotic Urology. University Center of Excellence in Urology. Wrocław Medical University)
Gallioli, Andrea (Institut d'Investigació Biomèdica Sant Pau)
Ferro, Matteo (European Institute of Oncology. Department of Urology. IRCCS)
Crocetto, Felice (Reproductive Sciences and Odontostomatology. University of Naples "Federico II". Department of Neurosciences)
Pandolfo, Savio Domenico (VCU Health. Division of Urology)
Autorino, Riccardo (D VCU Health. Division of Urology)
Belladelli, Federico (Division of Experimental Oncology. Unit of Urology. Urologicl Research Institute (URI). IRCCS)
Mari, Andrea (Oncologic Minimally Invasive Urology and Andrology Unit. Department of Experimental and Clinical Medicine. University of Florence. Careggi Hospital)
Busetto, Gian Maria (Department of Urology and Organ Transplantation. University of Foggia)
Li, Shufeng (Stanford University School of Medicine. Department of Dermatology)
Crivellaro, Simone (College of Medicine. University of Illinois. Department of Urology)
Chung, Benjamin Inbeh (Stanford University School of Medicine. Department of Urology)

Data:	2022
Resum:	Background: Transurethral resection of the prostate (TURP) is the gold-standard treatment for benign prostatic hyperplasia (BPH). However, laser surgery techniques (e. g. , photoselective vaporization of the prostate (PVP), holmium laser, thulium laser enucleation of the prostate (HoLEP or ThuLEP)), and minimally invasive treatment options (e. g. , UroLift) are increasingly replacing TURP. This study seeks to report the annual incidence, management trends, and costs of BPH procedures in the U. S. Methods: Data analyses of U. S. health insurance claims from 2004 to 2017, collected from the de-identified Optum Clinformatics Claims Database, were performed to determine the number of BPH patients and the treatment selected. Results: A total of 51,448 patients underwent BPH procedures from 2004 to 2017. There was a significant increase in the annual rate from 770 in 2004 to 6571 in 2017. The mean patient age (±SD) increased from 67. 6 years old (±8. 4) in 2004 to 73. 4 years old (±8. 4) in 2017. More than 60% of patients underwent cystourethroscopy and a post-void residual urine check for workup prior to surgical management. TURP was the most-common, and PVP was the second-most-common BPH procedure. Medical and total treatment costs increased, while the detection rate of prostate cancer after BPH surgery gradually decreased from 19. 87% in 2004 to 5. 78% in 2017. Conclusions: Our study demonstrates a recent trend in BPH management that replaces the traditional TURP technique with alternative methods. Due to rising costs, future studies should assess whether these newer methods are cost effective over the long term.
Drets:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.
Llengua:	Anglès
Document:	Article ; recerca ; Versió publicada
Matèria:	Benign prostatic hyperplasia ; Surgery ; Trend
Publicat a:	Applied sciences (Basel), Vol. 12 Núm. 17 (september 2022) , p. 8697, ISSN 2076-3417

DOI: 10.3390/app12178697

12 p, 1.4 MB

El registre apareix a les col·leccions:
Documents de recerca > Documents dels grups de recerca de la UAB > Centres i grups de recerca (producció científica) > Ciències de la salut i biociències > Institut de Recerca Sant Pau
Articles > Articles de recerca
Articles > Articles publicats